Skip to main content

UKPDS clinical trial summary slides

Glucose monitor, syringe, and pills

09-30-2018 | Medications | Clinical trial summary slides | Collection

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

This slide set outlines the results of the UKPDS33 study which compared the effects of intensive blood-glucose control with either sulfonylurea or insulin and conventional treatment on the risk of microvascular and macrovascular complications in patients with type 2 diabetes.

Metformin

09-30-2018 | Metformin | Clinical trial summary slides | Collection

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

This slide set outlines the results of the UKPDS34 study which investigated whether intensive glucose control with metformin had any specific advantage or disadvantage in patients with type 2 diabetes.

Blood pressure

09-30-2018 | Hypertension | Clinical trial summary slides | Collection

Long-term follow-up after tight control of blood pressure in type 2 diabetes

This slide set outlines the results of the post-trial monitoring of UKPDS which examined whether risk reductions for microvascular and macrovascular disease, achieved with the use of improved blood-pressure control during the trial, were sustained.

Glucose monitor and chart

09-30-2018 | Glycemic control | Clinical trial summary slides | Collection

10-year follow-up of intensive glucose control in type 2 diabetes

This slide set outlines the results of a 10-year, postinterventional follow-up of the UKPDS survivor cohort which examined whether a continued microvascular benefit from earlier improved glucose control was evident and whether such therapy had a long-term effect on macrovascular outcomes.